Department of Anesthesiology, University Hospitals Leuven, 3000, Leuven, Belgium.
Anesthesia and Intensive Care Department, CHU Rennes, 35000, Rennes, France.
Eur Spine J. 2021 Oct;30(10):2925-2935. doi: 10.1007/s00586-020-06661-8. Epub 2020 Nov 27.
With lumbar laminectomy increasingly being performed on an outpatient basis, optimal pain management is critical to avoid post-operative delay in discharge and readmission. The aim of this review was to evaluate the available literature and develop recommendations for optimal pain management after one- or two-level lumbar laminectomy.
A systematic review utilizing the PROcedure-SPECific Post-operative Pain ManagemenT (PROSPECT) methodology was undertaken. Randomised controlled trials (RCTs) published in the English language from 1 January 2008 until 31 March 2020-assessing post-operative pain using analgesic, anaesthetic and surgical interventions-were identified from MEDLINE, EMBASE and Cochrane Databases.
Out of 65 eligible studies identified, 39 RCTs met the inclusion criteria. The analgesic regimen for lumbar laminectomy should include paracetamol and a non-steroidal anti-inflammatory drug (NSAID) or cyclooxygenase (COX)-2 selective inhibitor administered preoperatively or intraoperatively and continued post-operatively, with post-operative opioids for rescue analgesia. In addition, surgical wound instillation or infiltration with local anaesthetics prior to wound closure is recommended. Some interventions-gabapentinoids and intrathecal opioid administration-although effective, carry significant risks and consequently were omitted from the recommendations. Other interventions were also not recommended because there was insufficient, inconsistent or lack of evidence.
Perioperative pain management for lumbar laminectomy should include paracetamol and NSAID- or COX-2-specific inhibitor, continued into the post-operative period, as well as intraoperative surgical wound instillation or infiltration. Opioids should be used as rescue medication post-operatively. Future studies are necessary to evaluate the efficacy of our recommendations.
随着腰椎板切除术越来越多地在门诊进行,最佳的疼痛管理对于避免术后出院延迟和再入院至关重要。本研究旨在评估现有文献并为单或双节段腰椎板切除术的最佳疼痛管理提供建议。
采用 PROcedure-SPECific Post-operative Pain ManagemenT(PROSPECT)方法进行系统评价。从 MEDLINE、EMBASE 和 Cochrane 数据库中确定了 2008 年 1 月 1 日至 2020 年 3 月 31 日期间发表的评估术后疼痛的使用镇痛、麻醉和手术干预的随机对照试验(RCT)。
在 65 项符合条件的研究中,有 39 项 RCT 符合纳入标准。腰椎板切除术的镇痛方案应包括术前或术中给予扑热息痛和非甾体抗炎药(NSAID)或环氧化酶(COX)-2 选择性抑制剂,并在术后继续使用,术后给予阿片类药物进行解救镇痛。此外,建议在关闭伤口前向手术切口内灌注或局部浸润局部麻醉剂。一些干预措施——加巴喷丁类药物和鞘内阿片类药物的应用——虽然有效,但存在显著风险,因此被排除在建议之外。其他干预措施也不被推荐,因为证据不足、不一致或缺乏证据。
腰椎板切除术的围手术期疼痛管理应包括扑热息痛和 NSAID 或 COX-2 特异性抑制剂,持续到术后,并在术中进行手术切口内灌注或局部浸润。术后应使用阿片类药物作为解救药物。需要进一步的研究来评估我们建议的疗效。